Intracellular Drug Delivery market Professional Survey Report by 2035

The growing demand for novel drugs that can acts as potential treatments for previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery systems that facilitate intracellular transport of therapeutics across the cytosol

Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely evolution of the market for non-viral drug delivery systems over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
 An executive summary of the key insights captured during our research
 A brief introduction to important concepts related to non-viral drug delivery systems, featuring information on need for target delivery, advanced approaches for delivery of drug payload and different type of delivery systems
 A detailed overview of the current market landscape of players engaged in the development of non-viral drug delivery systems, along with information on their year of establishment, company size and location of headquarters, type of company, geographical coverage, therapeutic portfolio, type of biologic delivered, type of molecule delivered, type of technology and type of linkage
 An insightful analysis based on the contemporary market trends in the non-viral drug delivery systems domain, along with information on type of technology, company size and type of molecule delivered, location of headquarters and company size and location of headquarters
 An insightful competitiveness analysis of players involved in the development on non-viral drug delivery systems in the healthcare domain
 Elaborate profiles of various prominent players that are currently engaged in the non-viral drug delivery domain
 A detailed analysis of the partnerships inked between various stakeholders, during the period 2015-2022
 An insightful analysis describing three crucial business decision making frameworks in the non-viral drug delivery domain namely Kalbach Innovation Model, competitive assessment framework and BCG matrix
 The report contains an exhaustive list of technologies for Intracellular Drug Delivery
 A detailed market forecast analysis, highlighting the likely growth of the non-viral drug delivery systems market, for the period 2023-2035
 Type of Molecule
 Small Molecule
 Biologic

 Type of Biologic
 Antibodies
 DNA
 RNA
 Proteins / Peptides

 Type of Technologies
 Cell Penetrating Peptides
 Extracellular Vesicles
 Oligonucleotides
 Nanoparticles
 Polymers

 Target Therapeutic Area
 Infectious Diseases
 Oncological Disorders
 Genetic Disorders
 Neurological Disorders
 Hepatic Disorders
 Cardiovascular Disorders
 Other Disorders

 Type Of Payment Model
 Upfront Payments
 Milestone Payments

 Key Geographical Regions
 North America
 Europe
 Asia
 Latin America
 Middle East and North Africa (MENA)
 Rest of the world

Key companies covered in the report
 Alnylam Pharmaceuticals
 AstraZeneca
 Biond Biologics
 Code Biotherapeutics
 Eli Lilly
 Merck
 Novartis
 Roche

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/non-viral-dr

News article
Genotoxicity Testing and Mutagenicity Testing Services Market

Learn from experts: do you know about these emerging industry trends?
Bioavailability Enhancement Technologies
Liposomes Development: Service Providers Landscape

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#intracellulardrugdeliverymarket #intracellulardrugdeliverymarketsize #drugdeliverysystems #intracellulardrugdelivery #cellpenetratingpeptides

Hydrogen Market Analysis by Trends, Size, Share, Growth Opportunities, and Emerging Technologies

The fertilizer industry uses high-volume of hydrogen to manufacture fertilizers, especially ammonia that is used to create nitrogen-based fertilizers. Ammonia is widely used in agricultural activities to maintain crop nutrition and increase productivity. Due to the declining area of arable land, the requirement for ammonia has grown significantly. Owing to this demand, the hydrogen market is expected to increase its size from $136,185.0 million in 2019 to $196,934.5 million by 2030. According to P&S Intelligence, the market will accelerate at a CAGR of 4.3% during the forecast period (2020–203.

Apart from this, hydrogen is used to separate sulfur compounds from crude oil and break long-chain hydrocarbons into short chains during the production of gasoline. Moreover, the surging demand for sour crude oil is fueling the need for hydrogen, as it requires extensive processing. Besides, stringent environmental regulations to decrease sulfur in oil are escalating the consumption of hydrogen at oil refineries. For example, in January 2020, the International Maritime Organization (IMO) enforced an additional 0.5% global cap on the sulfur content in fuel. This limit is in addition to the earlier limit of 3.5%.

Browse detailed report - https://www.psmarketresearch.c....om/market-analysis/h

The companies distribute hydrogen through cylinder, on-site generation, and tanker. They largely supply hydrogen via on-site generation, as it is easier to transport hydrogen through this channel and it is less complicated than using cylinders and tankers. Moreover, this method eradicates risks of the supply chain that includes unfavorable environmental conditions or low supply due to border closure. In the on-site generation method, the manufacturers produce hydrogen in the proximity of end-use factories and transport via pipelines. Besides, this method is cost-effective in comparison to tanker and cylinder distribution methods.

Thus, the expansion of oil refineries and fertilizer industry will fuel the consumption of hydrogen in coming years.

 

www.psmarketresearch.com

Hydrogen Market Research Report | Global Revenue Forecast, 2030

Hydrogen Market Predicted CAGR 4.3% between 2020 and 2030: Report Coverage - Production Process (Steam–Methane Reforming, Coal Gasification, Electrolysis, Partial Oxidation), Distribution Method (On-Site Generation, Cylinder, Tanker), End User (Chemi

India DG Set Market Share, Growing Demand, and Top Key Players

The India diesel genset market is advancing at a CAGR of 8.8% between 2022-2030 and will reach USD 1,839.5 million by 2030, mainly driven because of the demand for sable electricity and advancements in the technology.

The DG sets used in the commercial applications will grow the fastest in the years to come with a CAGR of 10%, these gensets provides uninterrupted power supply in several commercial applications including shopping malls, data centers, and healthcare sector to avoid irregular power supply.

Additionally, there is a growing demand for diesel gensets from residential application category for the backup and primary power supply in buildings..

Get More Insights: https://www.psmarketresearch.c....om/market-analysis/i

Based on power rating segment, 5 kVA–75 kVA category holds the largest share by volume. it is attributed to the low maintenance cost and easy availability of spare parts for these gensets throughout the country.

Additionally, demand to mitigate the primary and auxiliary power needs with the surge in economic developments will power the India DG set market in the years to come.

Karnataka will grow the fastest due to the rising investments in the telecom sector, developing commercial infrastructure and the rising demand for power backup in residential buildings. Further, state's infrastructure improvement initiatives will drive the need for diesel gensets in the coming years.

Hence, the Indian diesel genset industry is growing substantially, because of the country's economic development and increasing power needs across various sectors.

 

www.psmarketresearch.com

India Diesel Genset Market Size & Growth Forecast Through 2030

The Indian diesel genset market size estimated at $937.1 million in 2022, and it is expected to advance at a CAGR of 8.8% during 2022–2030, to reach $1,839.5 million by 2030.

Non-Viral Transfection Reagents market Share, Growth Analysis by 2035

Given the increasing focus on genetically modified therapies, there is a consequent rise in the demand for efficient gene delivery vectors; in recent years, innovators are actively evaluating the potential of non-viral transfection agents.
Therefore, driven by the growing demand for cell and gene therapies, and the active ongoing efforts of industry stakeholders, the non-viral transfection reagents and systems market is anticipated to grow at a steady pace in the foreseen future.

The future opportunity within the non-viral transfection reagents and systems market has been analyzed across the following segments:

 Non-Viral Based Transfection Methods
 Chemical-based Methods
 Physical-based Methods
 Other Methods

 End-Users
 Academic And Research Institutions
 Stem Pharmaceutical Companies
 Other End-Users

 Area of Application
 Clinical Applications
 Research Applications

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)

The “Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035” report features the following companies, which we identified to be key players in this domain:
 BEX
 Bio-Rad Laboratories
 BTX
 Celsion Corporation
 Genprex
 Inovio Pharmaceuticals
 MaxCyte
 MilliporeSigma
 NepaGene
 OZ Biosciences
 Thermo Fisher Scientific

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Non-Viral Transfection Reagents: Market Landscape

5. Electroporation-Based Transfection Systems: Market Landscape

6. Other Non-Viral Transfection Systems: Market Landscape

7. Company Competitiveness Analysis

8. Technology Competitiveness Analysis

9. Company Profiles

10. Potential Strategic Partners

11. Big Pharma Initiatives

12. Patent Analysis

13. Publication Analysis

14. Roots Analysis Pricing Strategy Framework

15. Market Sizing and Opportunity Analysis

16. Executive Insights

17. Conclusion

18. Appendix 1: Tabulated Data

19. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Digital Therapies: The “Digital Pills” of current generation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#nonviraltransfectionreagentsmarket #nonviraltransfectionreagentsmarketsize #nonviraltransfection #transfectionreagents #nonviraltransfectionreagents